BASF Poster

Developing a gastric resistant coating formulation can be quite demanding. There are a lot of interactions between polymer and active ingredient or non-functional excipients which have to be heeded. Even if all incompatibilities could be eliminated, the disintegration characteristics of the core…
Read More...

In the field of gastric resistant film-coating, a lot of obstacles can occur during formulation development. Some pharmaceutical actives (e.g. omeprazole) are prone to interactions with the functional polymer poly(methacrylic acid-co-ethyl acrylate) (MAE). Yet, one should consider that the coating…
Read More...

Various active pharmaceutical ingredients (APIs) are either aggressive to the stomach’s mucosa or vulnerable to the acidic nature of the gastric juice. Solid oral dosage forms carrying one of these APIs thence require gastric resistant functionality. Poly(methacrylic acid-co-ethyl acrylate) based…
Read More...

Various active pharmaceutical ingredients (APIs) are either aggressive to the stomach’s mucosa or vulnerable to the acidic nature of the gastric juice. Solid oral dosage forms carrying one of these APIs thence require gastric resistant functionality. Poly(methacrylic acid-co-ethyl acrylate) based…
Read More...

Various active pharmaceutical ingredients (APIs) are either aggressive to the stomach’s mucosa or vulnerable to the acidic nature of the gastric juice. Solid oral dosage forms carrying one of these APIs thence require gastric resistant functionality to prevent drug liberation and acid up-take in the…
Read More...

Since the development of polymers for enteric coating in the late 1950’s, numerous investigations have illustrated the application of these functional excipients such as poly(methacrylic acid-co-ethyl acrylate). Also mixtures with other polymers like poly(vinyl acetate) have already been well…
Read More...

Poly(vinyl acetate) – based matrix formulations are well known for obtaining strong sustained release functionality. Depending on the solubility of the active ingredient and the required dissolution profile, pore formers need to be added for adjusting drug release. The combination of both excellent…
Read More...

Discover BASF’s wide range of excipients for parenteral use meeting the highest quality standards as well as BASF’s unparalleled experience in quality and regulatory affairs. Click on the poster for a full view: PDF Download: EXCIPIENTS FOR PARENTERAL USE  More about BASF Pharmaceutical…
Read More...

Topical formulations may be used to deliver active pharmaceutical ingredients (APIs) to or through the skin. These formulations typically possess a relatively soft, spreadable consistency and are often formulated as either water-in-oil or oil-in-water emulsions. BASF offers an unparalleled…
Read More...

Did you know that Soluplus® also solubilizes drugs processed by wet granulation? Try Soluplus® and experience a new dimension in solubility and bioavailability enhancement. Soluplus® is an innovative excipient that enables new levels of solubility and bioavailability for poorly soluble active…
Read More...